Steven Drexler, MD
Anesthesiology · Mount Kisco, NYNPI 1427051309
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,921 of the $7,594 with a category attached, or 78.0%. It is spread thinly across 20 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,310 and has fallen 51.8% since, to $1,597 in 2025. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $23.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$776
- Bristol Myers Squibb$633
- AbbVie$596
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$523
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,92178%
- Other$1,67222%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 1 | $1,672 |
| Takeda Pharmaceuticals U.S.A., Inc. | 73 | $1,294 |
| Johnson & Johnson | 26 | $776 |
| Bristol Myers Squibb | 73 | $633 |
| AbbVie | 16 | $596 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $523 |
| QOL Medical, LLC | 34 | $517 |
| Lilly USA, LLC | 17 | $305 |
| Intercept Pharmaceuticals, Inc. | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. | 9 | $176 |
| Phathom Pharmaceuticals, Inc. | 3 | $158 |
| Sanofi | 2 | $147 |
| Ferring Pharmaceuticals Inc. | 6 | $141 |
| Madrigal Pharmaceuticals | 1 | $127 |
| Merck | 2 | $125 |
| Aimmune Therapeutics, Inc. | 3 | $98 |
| Redhill Biopharma Inc. | 2 | $42 |
| Exact Sciences | 2 | $39 |
| Ardelyx, Inc. | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,594 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Mount Kisco
- David ParkMount Kisco$12K
- Mark KronenfeldBrooklyn$2.4M
- Kiran PatelNew York$832K
- Karina GritsenkoBronx$665K
- Marc DicksteinNew York$585K
- Admir HadzicNew York$510K
- Christopher DimeoNew York$449K
- Christopher RieglerNew York$429K
- William UrmeyNew York$397K
- Sudhir DiwanNew York$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.